ASCO Breast Cancer Guidance: When Is Hormone Therapy Enough?

Welcome to Onco Life Centre Podcast.

This episode looks at ASCO's August 2026 guideline update on endocrine therapy for breast cancer, including when this treatment alone is enough and when doctors consider adding more.

You'll learn:
- Why ASCO updated its breast cancer treatment guidance in August 2026
- How doctors now estimate individual risk instead of relying on trial resemblance
- Why endocrine therapy remains the treatment foundation for hormone receptor-positive disease
- What the risk thresholds are for considering additional treatment
- How ovarian suppression works for premenopausal women
- Why extending treatment duration involves a trade-off with side effects
- What this update means for treatment duration going forward
- How doctors and patients weigh benefit against side effects together

This update reflects a broader shift in cancer care toward matching treatment intensity to each patient's actual risk, rather than following blanket rules.

Blog Link: ASCO Breast Cancer Guidance: When Is Hormone Therapy Enough?

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.